Nuveen Mortgage and Income Fund
Change company Symbol lookup
Select an option...
JLS Nuveen Mortgage and Income Fund
JNJ Johnson & Johnson
QIAN Qiansui International Group Co Ltd
BV Brightview Holdings Inc
PFE Pfizer Inc
MP Mp Materials Corp
WFG West Fraser Timber Co Ltd
MDT Medtronic PLC
ATMR^ Altimar Acquisition Corp II
AEG Aegon NV
Go

Company profile

Nuveen Mortgage and Income Fund (the Fund), formerly Nuveen Mortgage Opportunity Term Fund, is a non-diversified, closed-end management investment company. The Fund's investment objective is to generate attractive total returns through opportunistic investments in mortgage-backed security (MBS). It seeks to achieve its investment objective by investing primarily in non-agency residential MBS and commercial MBS. The Fund may also invest up to 20% of its managed assets in other permitted investments, including cash and cash equivalents, the United States treasury securities, non-mortgage related asset-backed securities, inverse floating rate securities, municipal securities, interest rate futures, interest rate swaps and swaptions, non-MBS credit default swaps and other synthetic mortgage-related exposure, including equity investments in mortgage real estate investment trusts (REITs). The Fund's investment advisor is Nuveen Fund Advisors, LLC.

Closing Price
$21.02
Day's Change
-0.0666 (-0.32%)
Bid
--
Ask
--
B/A Size
--
Day's High
21.10
Day's Low
21.01
Volume
(Heavy Day)
Volume:
13,970

10-day average volume:
8,258
13,970

Lawsuits Filed Against ROOT, EBON and ACAD - Jakubowitz Law Pursues Shareholders Claims

2:31 pm ET May 5, 2021 (Accesswire) Print

NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.

Root, Inc (NASDAQ:ROOT)

CONTACT JAKUBOWITZ ABOUT ROOT:

https://claimyourloss.com/securities/root-inc-loss-submission-form/?id=15511&from=1

This lawsuit is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Root Class A common stock pursuant and/or traceable to the Offering Documents issued in connection with the Company's initial public offering conducted on or about October 28, 2020.

Lead Plaintiff Deadline : May 18, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Root would foreseeably fail to generate positive cash flow for at least several years following the IPO; (ii) accordingly, the Company would foreseeably require significant cash infusions to meet its cash flow needs; (iii) notwithstanding the Defendants' touting of Root's purportedly unique, data-driven advantages, several of the Company's established industry peers in fact possessed significant competitive advantages over Root with respect to, inter alia, telematics data and data engagement; and (iv) as a result, the Offering Documents and Defendants' public statements throughout the Class Period were materially false and/or misleading and failed to state information required to be stated therein.

Ebang International Holdings Inc. (NASDAQ:EBON)

CONTACT JAKUBOWITZ ABOUT EBON:

https://claimyourloss.com/securities/ebang-international-holdings-inc-loss-submission-form/?id=15511&from=1

Class Period : June 26, 2020 - April 5, 2021

Lead Plaintiff Deadline : June 7, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the proceeds from Ebang's public offerings had been directed to an low yield, long term bonds to an underwriter and to related parties rather than used to develop the Company's operations; (2) Ebang's sales were declining and the Company had inflated reported sales, including through the sale of defective units; (3) Ebang's attempts to go public in Hong Kong had failed due to allegations of embezzling investor funds and inflated sales figures; (4) Ebang's purported crytocurrency exchange was merely the purchase of an out-of-the-box crypto exchange; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

CONTACT JAKUBOWITZ ABOUT ACAD:

https://claimyourloss.com/securities/acadia-pharmaceuticals-inc-loss-submission-form/?id=15511&from=1

Class Period : June 15, 2020 - April 4, 2021

Lead Plaintiff Deadline : June 18, 2021

The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Image: https://www.accesswire.com/users/newswire/images/644925/tj_logo_bluegrey.png

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW

1140 Avenue of the Americas

9th Floor

New York, New York 10036

T: (212) 867-4490

F: (212) 537-5887

SOURCE: Jakubowitz Law

View source version on accesswire.com:

https://www.accesswire.com/644925/Lawsuits-Filed-Against-ROOT-EBON-and-ACAD--Jakubowitz-Law-Pursues-Shareholders-Claims

comtex tracking

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.